Methods for shrinking pituitary tumors
作者： Moraitis Andreas
DOI:
关键词: Internal medicine 、 Pituitary tumors 、 Medicine 、 Oncology 、 Chemotherapy
摘要: Relacorilant may be orally administered for the treatment of pituitary tumors. to a fasted patient, or fed patient. in conjunction with other tumor targeting treatments, including surgical radiation chemotherapy carcinomas, and pharmaceutical treatments.
lens.org 参考文章(9)
Tony Johnson, Nicholas Ray, Iain Walters, Hazel Hunt, Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators ,(2013)
Maria Fleseriu, Beverly M. K. Biller, James W. Findling, Mark E. Molitch, David E. Schteingart, Coleman Gross, Richard Auchus, Timothy Bailey, Beverly M. K. Biller, Ty Carroll, Kathleen Colleran, Henry Fein, James W. Findling, Maria Fleseriu, Amir Hamrahian, Laurence Katznelson, Janice Kerr, Mark Kipnes, Lawrence Kirschner, Christian Koch, Sam Lerman, Timothy Lyons, Michael McPhaul, Mark E. Molitch, David E. Schteingart, T. Brooks Vaughan, Roy Weiss, , , Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome The Journal of Clinical Endocrinology and Metabolism. ,vol. 97, pp. 2039- 2049 ,(2012) , 10.1210/JC.2011-3350
Stephen J. Winters, Todd Vitaz, Michael R. Nowacki, Durrett C. Craddock, Craig Silverman, Fred A. Lopez, Addison's Disease and Pituitary Enlargement The American Journal of the Medical Sciences. ,vol. 349, pp. 526- 529 ,(2015) , 10.1097/MAJ.0000000000000305
Daniel Cuevas-Ramos, Maria Fleseriu, Treatment of Cushing's disease: a mechanistic update Journal of Endocrinology. ,vol. 223, ,(2014) , 10.1530/JOE-14-0300
Maria Fleseriu, James W. Findling, Christian A. Koch, Sven-Martin Schlaffer, Michael Buchfelder, Coleman Gross, Changes in plasma ACTH levels and corticotroph tumor size in patients with Cushing's disease during long-term treatment with the glucocorticoid receptor antagonist mifepristone. The Journal of Clinical Endocrinology and Metabolism. ,vol. 99, pp. 3718- 3727 ,(2014) , 10.1210/JC.2014-1843
Joseph K. Belanoff, Andreas G. Moraitis, Use of glucocorticoid receptor antagonist and somatostatin analogues to treat acth-secreting tumors ,(2016)
Hazel J. Hunt, Joseph K. Belanoff, Iain Walters, Benoit Gourdet, Jennifer Thomas, Naomi Barton, John Unitt, Timothy Phillips, Denise Swift, Emily Eaton, Identification of the Clinical Candidate (R)-(1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) Antagonist. Journal of Medicinal Chemistry. ,vol. 60, pp. 3405- 3421 ,(2017) , 10.1021/ACS.JMEDCHEM.7B00162
Hazel Hunt, Kirsteen Donaldson, Mark Strem, Vanessa Zann, Pui Leung, Suzanne Sweet, Alyson Connor, Dan Combs, Joseph Belanoff, Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacological Effect of Orally Administered CORT125134: An Adaptive, Double-Blind, Randomized, Placebo-Controlled Phase 1 Clinical Study Clinical Pharmacology in Drug Development. ,vol. 7, pp. 408- 421 ,(2018) , 10.1002/CPDD.389